Milwaukee-based Dohmen Life Science Services, a provider of outsourced business services for biopharma and medtech innovators, announced Tuesday that it has acquired Siren Interactive Corporation, a rare disease relationship marketing company located in Chicago.
The acquisition is said to further expand Dohmen’s market by helping life science companies in the rare disease space locate, educate and interact with the patients they serve.
“Healthcare is shifting from a one size fits all model driven by volume to a more precise and bespoke care model driven by value,” said Cynthia LaConte, chief executive officer of Dohmen Life Science Services. “We created and launched DLSS as a platform for life science innovators to reach smaller, more targeted patient populations in the most direct and interactive way possible.
“Siren shares our desire to drive innovation by helping life science innovators reach people suffering from rare disease. Whether in development, diagnosis or day-to-day care, there are unique challenges faced by this community. Siren understands these complexities and has overcome them by successfully connecting rare disease patients with life science innovators for more than 15 years.”
“Dohmen shares our commitment to improving the quality of life for people with rare disease,” said Siren founder and CEO Wendy White, who will join Dohmen as senior vice president of the rare disease segment. “Our communications and marketing capability combined with Dohmen’s expertise in finance, technology, supply chain, medical and regulatory affairs and patient support services has the power to really revolutionize the way products and services are developed and delivered to this unique community. The Siren team is excited about joining a company with such a rich tradition of innovation and helping to create a brand new patient care model.”